伴随性失眠和睡眠呼吸暂停:挑战和治疗方法
Kathleen M Sarber1, Reena Dhanda Patil2
1Uniformed Services University of the Health Sciences, Bethesda, MD, USA; Otolaryngology, Wilford Hall Ambulatory Surgery Center, 1100 Wilford Hall Loop, San Antonio, TX 78236, USA.
Otolaryngologic clinics of North America
|March 26, 2024
概括
失眠和阻塞性睡眠呼吸暂停 (OSA) 经常一起发生. 手术,就像低分泌神经刺激一样,可以改善疾病和患者对治疗的坚持.
科学领域:
- 睡眠医学 睡眠医学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 失眠和阻塞性睡眠呼吸暂停 (OSA) 是常见的,经常同时发生的睡眠障碍.
- 失眠的认知行为疗法 (CBT-I) 是一线失眠治疗,改善了对OSA的阳性气道压力 (PAP) 治疗的坚持.
- 替代性OSA治疗可能会为患有并发性失眠和睡眠呼吸暂停 (COMISA) 的患者提供更好的接受.
研究的目的:
- 探索伴随性失眠患者阻塞性睡眠呼吸暂停 (OSA) 的替代治疗方法.
- 为了评估低分泌神经刺激对COMISA的疗效和耐受性.
- 强调耳鼻喉科医生在管理COMISA中的作用.
主要方法:
- 关于COMISA治疗的当前文献的综述.
- 在患有OSA和失眠的患者中,对低分泌神经刺激的结果进行分析.
- 讨论多学科管理策略.
主要成果:
- 低分泌神经刺激是OSA的一种耐受性良好的手术选择.
- 这种外科手术也可能导致并发性失眠症状的改善.
- 在寻求手术治疗OSA的患者中,COMISA是一种常见的表现.
结论:
- 耳鼻喉科医生应在考虑手术治疗OSA的患者中识别COMISA.
- 低分泌神经刺激为COMISA提供了一个可行的替代治疗选择.
- 多学科的方法是必要的,以最佳的管理患者的伴随性失眠和睡眠呼吸暂停.
关键词:
治疗失眠的认知行为疗法 (CBT-i)同病性失眠和阻塞性睡眠呼吸暂停 (COMISA)低分泌神经刺激 低分泌神经刺激失眠是一种失眠.部推进装置是一种部推进装置.阻塞性睡眠呼吸暂停症是什么阳性气道压力 (PAP) 治疗疗法睡眠手术是睡眠手术.更多相关视频
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
768
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
19.8K
相关概念视频
Sleep Apnea
149
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
149
Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Sleepwalking and Sleep Talking
158
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
158
CNS Depressants: Barbiturates and Benzodiazepines
259
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
259
Narcolepsy
102
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
102
